Thumbnail Image
Publication

Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): A European survey conducted by the European Society for Medical Oncology (ESMO) Young Oncologists Committee.

Califano, Raffaele
; 
Karamouzis, M
; 
Banerjee, S
; 
de Azambuja, E
; 
Guarneri, V
; 
Hutka, M
; 
Jordan, K
; 
Kamposioras, K
; 
Martinelli, E
; 
Corral, J
... show 4 more
Citations
Altmetric:
Abstract
Early stage Non-Small Cell Lung Cancer (NSCLC) is potentially curable with surgery. ESMO guidelines recommend cisplatin-based adjuvant chemotherapy (CT) for completely resected stage II-III NSCLC. There is limited evidence for the use of adjuvant CT and/or radiotherapy (RT) in incompletely resected (R1) early stage NSCLC.
Authors
Califano, Raffaele
Karamouzis, M
Banerjee, S
de Azambuja, E
Guarneri, V
Hutka, M
Jordan, K
Kamposioras, K
Martinelli, E
Corral, J
Postel-Vinay, S
Preusser, M
Porcu, L
Torri, V
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom; Department of Medical Oncology, University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom.
Description
Date
2014-03-16
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Article
Citation
Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): A European survey conducted by the European Society for Medical Oncology (ESMO) Young Oncologists Committee. 2014: Lung Cancer
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/320615
Embedded videos